This marks the first of what I hope to be many times to address you and my colleagues on an issue that I have been graced with having the responsibility to deal in the public policy arena, and that's the issue of nuclear waste. When people talk about nuclear waste and this debate about where it is and why it's there, they primarily talk about our nuclear utilities. Especially after Fukushima Daiichi, people understand that when you store high-level nuclear waste onsite and if there's a disaster that occurs and if the pools run dry, then you might have a melting which might spread radioactivity, and that's not good for anybody. That's a good debate to have because we have nuclear waste stored all over this country. But I'm not here really to talk about the private for-profit sector, the nuclear industry today. I'm here to tell another story, another story that really talks about why we have government and why there's still a need for some government entities. Back during World War II--and we just heard my colleague talk about the Honor Flights--back during World War II, we decided as a Nation to win these wars. One way to make sure that we wouldn't lose thousands upon thousands of soldiers in an invasion of Japan was to develop the nuclear bomb. Two were dropped; the war ended. Many people historically know that development, that occurred because of the Manhattan Project.…
Share & report
More from John Shimkus
And that device that you have is a per- or polyfluorinated compound; is that correct?
So let's find the ones that we can agree upon and move into law. We worked diligently, and it was mentioned before--so the debate is also going to come and say, Republicans hate people, we hate health. Nothing is going to be done. We have…
They say in this letter: ``Any Federal action should not address PFAS as a class or with predetermined outcomes, but rather should be based on sound science and the weight of the scientific evidence.'' As I said before, this is the first…
Do you want 10 new drugs, 30 new drugs on the market, 100 new drugs on the market or zero? H.R. 3 removes research and development investments, which will hinder innovation. Innovation doesn't always mean higher cost. Take hepatitis C…





